AMCR
Amcor plc
AMCR offers stronger fundamentals, but that advantage does not outweigh its weaker overall profile.
AMZN
Amazon.com, Inc.
AMZN has the edge over AMCR overall, supported by stronger modeled upside and stronger valuation.
AMCR Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Stable | |
| Weak |
AMCR's revenue and profitability are currently healthy, and its cash flow is stable, but its balance sheet is weak.
AMZN Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Weak | |
| Healthy |
AMZN's revenue, profitability and balance sheet are currently healthy, but its cash flow is weak.
AMCR PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 17x | $38.71 | -12% |
| Current | 19x | $43.80 | — |
| Fair | 21x | $49.43 | +13% |
| Expensive | 28x | $64.25 | +47% |
Historical ranges are pointers, not guarantees.
AMCR's PE is in its cheap range at 19x.
AMZN PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 22x | $267 | — |
| Forward | 27x | $267 | — |
| Cheap | 34x | $415 | +55% |
| Fair | 60x | $745 | +179% |
| Expensive | 102x | $1,262 | +372% |
Historical ranges are pointers, not guarantees.
AMZN has the edge over AMCR in the historical PE scenario, which offers more potential upside but is not a forecast.
AMCR Forward outlook
There aren't enough analyst estimates for AMCR to show an outlook.
AMZN Forward outlook
| Metric | Outlook |
|---|---|
| Strongly deteriorating | |
| Strong growth | |
| Growth | |
| Improving | |
| Moderate | |
| Moderate |
Analysts expect earnings and revenue growth for AMZN, with profitability improving.
AMCR Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | $2.33 | +36% |
| Q2 2026 | $2.38 | +31% |
| Q1 2026 | $1.45 | -48% |
| Q4 2025 | $1.53 | -45% |
| Q3 2025 | $1.71 | -36% |
| Q2 2025 | $1.81 | -28% |
| Q1 2025 | $2.80 | +24% |
| Q4 2024 | $2.76 | +25% |
AMCR's earnings per share have fallen from their peak: $2.33 over the past year, against $3.56 in late 2022.
AMZN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $9.87 | -20% |
| Q3 2026 | $12.37 | +75% |
| Q2 2026 | $12.43 | +89% |
| Q1 2026 | $8.36 | +36% |
| Q4 2025 | $7.17 | +30% |
| Q3 2025 | $7.08 | +52% |
| Q2 2025 | $6.56 | +57% |
| Q1 2025 | $6.14 | +72% |
| Q4 2024 | $5.53 | +91% |
AMZN has the edge over AMCR on earnings, with more consistent year-over-year improvement.
AMCR Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $6.1B | +6.7% |
| Q2 2026 | $6.4B | +26% |
| Q1 2026 | $5.9B | +77% |
| Q4 2025 | $5.4B | +68% |
| Q3 2025 | $5.7B | +71% |
| Q2 2025 | $5.1B | +44% |
| Q1 2025 | $3.3B | -2.3% |
| Q4 2024 | $3.2B | -0.3% |
AMCR's revenue has grown year over year for six quarters in a row: $6.1B last quarter, up 6.7% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 7.4% | -0.6 points |
| Q2 2026 | 10% | +8.4 points |
| Q1 2026 | 7.8% | -1.6 points |
| Q4 2025 | 6.1% | -3.1 points |
| Q3 2025 | 8% | -1.3 points |
| Q2 2025 | 1.7% | -9.5 points |
| Q1 2025 | 9.4% | +0.4 points |
| Q4 2024 | 9.2% | +1.7 points |
AMCR's operating margin was 7.4% last quarter, down 0.6 points from the same quarter a year ago.
AMZN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $201.9B | +12% |
| Q2 2026 | $200.6B | +20% |
| Q1 2026 | $181.5B | +17% |
| Q4 2025 | $213.4B | +14% |
| Q3 2025 | $180.2B | +13% |
| Q2 2025 | $167.7B | +13% |
| Q1 2025 | $155.7B | +8.6% |
| Q4 2024 | $187.8B | +10% |
AMZN's revenue has grown year over year every quarter since late 2020: $202B last quarter, up 12% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 14% | +4.2 points |
| Q2 2026 | 14% | +2.3 points |
| Q1 2026 | 13% | +1.3 points |
| Q4 2025 | 12% | +0.4 points |
| Q3 2025 | 9.7% | -1.3 points |
| Q2 2025 | 11% | +1.5 points |
| Q1 2025 | 12% | +1.1 points |
| Q4 2024 | 11% | +3.5 points |
AMZN has the edge over AMCR on profitability, with a higher operating margin.
AMCR Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$828M | -$457M |
| Q2 2026 | $1.4B | +52% |
| Q1 2026 | -$42M | -$42M |
| Q4 2025 | $282M | -15% |
| Q3 2025 | -$371M | +$43M |
| Q2 2025 | $894M | +11% |
| Q1 2025 | $0 | -100% |
| Q4 2024 | $330M | +36% |
AMCR has the edge over AMZN on cash generation, producing positive trailing cash flow while its opponent burns cash.
AMZN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$34.8B | -8202% |
| Q2 2026 | -$8.8B | -2757% |
| Q1 2026 | -$18.2B | -$10.2B |
| Q4 2025 | $14.9B | -16% |
| Q3 2025 | $430M | -87% |
| Q2 2025 | $332M | -96% |
| Q1 2025 | -$8B | -297% |
| Q4 2024 | $17.8B | -36% |
AMZN's free cash flow was −$46.9B over the past year, against $10.6B the year before.
AMCR Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.2% | +800K shares |
| 1 year | +0.3% | +1.6M shares |
| 3 years | +57% | +169M shares |
| 5 years | +49% | +153M shares |
| Available history | +44% | +142M shares |
AMCR has the edge over AMZN on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q2 2026 | — |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
| Q2 2024 | — |
| Q1 2024 | — |
| Q4 2023 | — |
AMZN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.2% | +26M shares |
| 1 year | +0.8% | +84M shares |
| 3 years | +3.5% | +371M shares |
| 5 years | +6.1% | +629M shares |
| Available history | +8.2% | +829M shares |
AMZN has 10.9B diluted shares, up 0.8% from a year ago.
| Quarter | Spent |
|---|---|
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
| Q2 2023 | — |
| Q1 2023 | — |
| Q4 2022 | — |
| Q3 2022 | — |
| Q2 2022 | $3.3B |
AMCR Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 4.2x | High |
| Q2 2026 | 3.9x | Elevated |
| Q1 2026 | 5.2x | High |
| Q4 2025 | 5.9x | High |
| Q3 2025 | 6.7x | High |
| Q2 2025 | 7.7x | High |
| Q1 2025 | 3.6x | Elevated |
| Q4 2024 | 3.5x | Elevated |
AMCR's net debt is about 4.2 years of its operating earnings (EBITDA), down from 6.7 years a year ago.
AMZN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.7x | Very low |
| Q2 2026 | 0.3x | Very low |
| Q1 2026 | 0.1x | Very low |
| Q4 2025 | -0.1x | Net Cash |
| Q3 2025 | -0.1x | Net Cash |
| Q2 2025 | -0.0x | Net Cash |
| Q1 2025 | -0.1x | Net Cash |
| Q4 2024 | -0.2x | Net Cash |
AMZN has the edge over AMCR on leverage, with a lower net debt burden relative to earnings.
AMCR Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 50.1 | Neutral |
| Stochastic | 53.5 | Neutral |
AMCR's weekly RSI is 50 (neutral) and its Stochastic is 54 (neutral).
AMZN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 57.1 | Neutral |
| Stochastic | 50.0 | Neutral |
AMZN's weekly RSI is 57 (neutral) and its Stochastic is 50 (neutral).
AMCR PE vs Consumer Cyclical Sector
| Metric | AMCR | Sector median | Relative |
|---|---|---|---|
| PE | 19x | 18x | 4.1% above |
| PE % | 27 | 47 | 20 pts below |
AMCR has the edge over AMZN on valuation relative to its sector.
AMZN PE vs Consumer Cyclical Sector
| Metric | AMZN | Sector median | Relative |
|---|---|---|---|
| PE | 22x | 18x | 20% above |
| PE % | 4 | 47 | 43 pts below |
AMZN is trading at 22x earnings, a 20% premium to the Consumer Cyclical sector's median of 18x, though its recent earnings include one-off gains.
AMCR Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $44.0 | 0.5% below |
| 20 week MA | $44.6 | 1.8% below |
| 50 week MA | $42.9 | 2% above |
| 100 week MA | $44.3 | 1.2% below |
| 200 week MA | $47.4 | 7.5% below |
AMCR's trend is mixed: it's above one of its five weekly moving averages, and 7.5% below its 200-week average.
AMZN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $253.6 | 5.5% above |
| 20 week MA | $254.9 | 4.9% above |
| 50 week MA | $242.5 | 10% above |
| 100 week MA | $229.6 | 17% above |
| 200 week MA | $191.4 | 40% above |
AMZN has the edge over AMCR on trend strength, trading above more of its moving averages.
AMCR Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $54.8 | $58.2 | +6.3% |
| 2021 | $58.2 | $58.3 | +0.2% |
| 2022 | $58.3 | $60.3 | +3.4% |
| 2023 | $60.3 | $48.2 | -20% |
| 2024 | $48.2 | $47.2 | -2.1% |
| 2025 | $47.2 | $41.6 | -12% |
| 2026 YTD | $41.6 | $43.8 | +5.3% |
AMCR has finished three years in a row lower, and it's up 5.3% so far in 2026.
AMZN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $93.5 | $158.6 | +70% |
| 2021 | $158.6 | $171.1 | +7.8% |
| 2022 | $171.1 | $85.3 | -50% |
| 2023 | $85.3 | $151.9 | +78% |
| 2024 | $151.9 | $223.8 | +47% |
| 2025 | $223.8 | $232.5 | +3.9% |
| 2026 YTD | $232.5 | $267.4 | +15% |
AMZN has the edge over AMCR on returns for 2026, with the stronger performance.